Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses

被引：15

作者：

Crawford, Ann ^{[1
]}

Jewell, Sally ^{[1
]}

Mara, Holly ^{[1
]}

McCatty, Laura ^{[1
]}

Pelfrey, Regina ^{[1
]}

机构：

[1] Lash Grp, Frisco, TX USA

来源：

PATIENT PREFERENCE AND ADHERENCE | 2014年 / 8卷

关键词：

multiple sclerosis; disease-modifying therapy; injection; nurse; DISEASE-MODIFYING THERAPIES; INJECTION-SITE REACTIONS; PREDICTIVE-VALIDITY; IMPROVE ADHERENCE; MEDICATION; MULTICENTER; STRATEGIES; IMPACT;

D O I：

10.2147/PPA.S67334

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article discusses the many ways that nurses can address the factors that lead to treatment fatigue in patients with multiple sclerosis (MS) on long-term disease-modifying therapy, ultimately helping to preserve the patient's health and quality of life. Patients with MS on long-term therapy may suffer from treatment fatigue and poor adherence due to a variety of different factors, including difficulties with injections, anxiety/depression, financial problems, and inaccurate beliefs about the MS disease process. Because MS nurses have regular interactions with patients, they are ideally situated to help patients cope with these and other factors that may limit adherence.

引用

页码：1093 / 1099

页数：7

共 32 条

[1]

Brandes DW, 2009, CURR MED RES OPIN, V25, P77, DOI [10.1185/03007990802569455, 10.1185/03007990802569455 ]

[2] Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devices. [J].